News | Population Health | January 04, 2017

Smartphone Apps May Help Study Cardiovascular Health, Behaviors

High participation rates help build large data set quickly, but research team reports limitations remain

smartphone apps, cardiovascular health, Stanford University study, patient self-reporting, population health

January 4, 2017 — In a study published online by JAMA Cardiology, researchers from Stanford University assessed the feasibility of measuring physical activity, fitness and sleep from smartphones. The goal was to gain insight into activity patterns associated with life satisfaction and self-reported disease.1

Studies have established the importance of physical activity, fitness, sleep and diet for cardiovascular health, yet these studies were completed with time-consuming, in-person measurements with substantial reliance on participant recall. Mobile technology, in particular advances in smartphone sensors, offers a new approach to the study of cardiovascular health and fitness. Direct measurement of activity through always-on, low-power motion chips provides a promising alternative to questionnaire-based approaches.

In 2015, Apple Inc. introduced an open-source framework to facilitate clinical research and standardization of data collection. One of the launch smartphone apps for the framework, MyHeart Counts, is a cardiovascular health study administered entirely via smartphone, incorporating direct sensor-based measurements of physical activity and fitness, as well as questionnaire assessment of sleep, lifestyle factors, risk perception and overall well-being.

From the launch to the time of the data freeze for this study (March to October 2015), the number of individuals (self-selected) who consented to participate was 48,968, representing all 50 states and the District of Columbia. Their median age was 36 years, and 82 percent were male. In total, 40,017 (82 percent of those who consented) uploaded data. Among those who consented, 42 percent completed four of the seven days of motion data collection, and 9 percent completed all seven days. Among those who consented, 82 percent filled out some portion of the questionnaires, and 10 percent completed the six-minute walk test, made available only at the end of seven days.

"Our study found five main results. First, we demonstrate the feasibility of consenting and engaging a large population across the United States using only smartphones. Second, we show that large-scale data can be gathered in real time from mobile devices, stored securely, transferred, deidentified and shared securely, including with participants. Third, we find that a data set for the six-minute walk test larger than any previously collected could be generated in weeks. Fourth, we report that state transition patterns of activity, not just absolute activity, relate to the reported presence of disease. Fifth, we conclude that there is a poor association between perceived and recorded physical activity, as well as perceived and formally estimated risk," the authors wrote.

"Most important, we also present the major challenges and limitations of mobile health research, including the skewed age and sex of participants, plus the rapid drop-off in engagement over time, with the resulting loss of data collection for several measures. To realize the promise of this novel approach to population health research, participant engagement needs to be optimized to maximize full participation of those who have expressed at least enough interest to download the app and consent to join the study."

"Large-scale, real-world assessment of physical activity, fitness and sleep using mobile devices may be a useful addition to future population health studies," the researchers concluded.

Read the article "How Smartphones and Apps May Change the Face of Healthcare."

For more information: www.jamanetwork.com/journals/jamacardiology

References

1. McConnell, M.V., Shcherbina, A., Pavlovic, A., et al. "Feasibility of Obtaining Measures of Lifestyle From a Smartphone App: The MyHeart Counts Cardiovascular Health Study," JAMA Cardiology. Published online Dec. 14, 2016. doi:10.1001/jamacardio.2016.4395


Related Content

News | Cardiovascular Clinical Studies

Nov. 18, 2024 — Silence Therapeutics presented end-of-treatment data from its Phase 2 ALPACAR-360 study of zerlasiran, a ...

Home November 18, 2024
Home
News | Cardiovascular Clinical Studies

Aug. 15, 2024 — According to a new study being presented at ACC Asia 2024 in Delhi, India, drinking over 400 mg of ...

Home August 14, 2024
Home
Videos | Cardiovascular Clinical Studies

As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits ...

Home July 30, 2024
Home
News | Cardiovascular Clinical Studies

July 25, 2024 — BioCardia, Inc., a global leader in cellular and cell-derived therapeutics for the treatment of ...

Home July 25, 2024
Home
News | Cardiovascular Clinical Studies

July 18, 2024 — Elucid, a pioneering AI medical technology company providing physicians with imaging analysis software ...

Home July 18, 2024
Home
News | Cardiovascular Clinical Studies

July 10, 2024 — CellProthera, a private company specializing in cell-based therapies for repairing ischemic tissues, and ...

Home July 10, 2024
Home
News | Cardiovascular Clinical Studies

July 9, 2024 — Microbot Medical Inc. announced the completion of the first procedure in a patient utilizing its LIBERTY ...

Home July 09, 2024
Home
News | Cardiovascular Clinical Studies

June 26, 2024 — Semaglutide, a medication initially developed for type 2 diabetes and obesity, significantly improves ...

Home June 26, 2024
Home
News | Cardiovascular Clinical Studies

June 21, 2024 — Lexicon Pharmaceuticals, Inc. announced that the peer-reviewed Journal of the American College of ...

Home June 21, 2024
Home
News | Cardiovascular Clinical Studies

June 20, 2024 — Microbot Medical Inc. announced its agreement with Brigham and Women’s Hospital (BWH), a leading ...

Home June 20, 2024
Home
Subscribe Now